Dr. Yolanda de Diego Otero graduated with a bachelors in Biology from the Universidad de Sevilla, she is a doctor in Molecular and Cellular Biology. She completed her postdoctoral training at the Department of Clinical Genetics at the Erasmus University in Rotterdam (The Netherlands) and at the Department of Pharmacology at the Faculty of Medicine of the Universidad de Málaga. She has been dedicated to study fragile X syndrome and other neurodevelopmental disorders for almost 30 years. Her research has used a mutant mouse model that manifests fragile X syndrome and the preclinical results showed a possible therapeutic target for the disease by treating brain oxidative stress. She currently coordinates the research group CTS546, based since 2002 at the Hospital Regional Universitario. She has participated as principal investigator in numerous research projects and clinical trials. Their results have been published in high-impact international journals. In addition, she has participated as a speaker, scientific committee and organizer of conferences both in Spain and internationally. She has active participation in societies and associations focused on the study and dissemination of information about fragile X syndrome, autism, and other child development disorders.